Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Interview: Dirk Knüppel, Meine Radiologie

Imaging and radiology is hot at the moment - especially in Germany. The next five years are going to see a huge amount of consolidation according to Dirk Knüppel, CEO at EQT-backed Meine Radiologie & Blikk Holding (MRBH) and HBI 2022 panellist. HBI caught up with him to find out more about his group's plans to expand across Europe.
April 7, 2022

Doctolib France’s biggest Unicorn

Now the largest unicorn in France, Doctolib is valued at €5.8b, three years after it reached unicorn status, despite still making a loss. HBI speaks to a French healthcare consultant and expert to find out how.
March 24, 2022

How can you build a successful health care science cluster in Europe?

Europe, with its often rigorous divides between research institutes and university hospitals, has fallen a long way behind power houses such as MIT/Harvard/Mass General in the generation of applied medical science. So how do you build a successful healthcare science cluster in Europe?
March 24, 2022

“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
March 24, 2022

Merger set to create €2bn revenue German hospital giant

Two of Germany’s largest not-for-profit hospitals are set to merge and form a chain to rival the likes of Helios, Sana Kliniken and Asklepios. Should these large for-profits be worried? HBI speaks with Dr Günter Merschbächer, Managing Director at one of the groups, not-for-profit Marienhaus, to find out more.
March 17, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022

Interview: Dagmar Dvorakova, CEO and Prof. Dr. Roland Staudinger, managing director, Aquilia Health Group

Smart reha, medical malls, how to best deploy new medtech, Fresenius Vamed veterans both, Dagmar and Roland are full of ideas on how to best build and run health care service models from acute hospitals to rehab and outpatient. Two and a half years ago they quit the mothership to set up Aquila which now employs 45 and runs projects in China, SE Asia, Austria, Germany and the Czech Rep.
March 16, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us